Proposed

sion Aid Standards developed by the IPDAS Collaboration
using information provided by the applicant and the agency's
medical director.
(b) The agency's medical director may use the results of
the assessment in whole or part as the basis for a certification
determination.
(5) The agency's medical director may establish minimum
scores in each of the following criteria: Content criteria,
development process criteria, and effectiveness criteria,
based on IPDAS Collaboration criteria, necessary to qualify
as a certified patient decision aid.
NEW SECTION
WAC 182-60-030 Certification fees. (1) The agency
will charge a certification fee to the applicant to defray the
costs of the assessment and certification under this chapter.
(a) Fees will be based on the cost of obtaining an assessment.
(b) One certification fee will apply to each review of a
patient decision aid.
(2) Applicants requesting review and certification of a
patient decision aid must pay a fee established by the agency
to defray the cost of review by a contracted review organization
or group.
WSR 12-21-110
PROPOSED RULES
HEALTH CARE AUTHORITY
(Medicaid Program)
[Filed October 23, 2012, 1:24 p.m.]
Original Notice.
Preproposal statement of inquiry was filed as WSR 12-
09-080.
Title of Rule and Other Identifying Information: WAC
182-530-1000 Outpatient drug program—General and 182-
531-0100 Scope of coverage for physician-related and health
care professional services—General and administrative.
Hearing Location(s): Health Care Authority (HCA),
Cherry Street Plaza Building, Sue Crystal Conference Room
106A, 626 8th Avenue, Olympia, WA 98504 (metered public
parking is available street side around building. A map is
available at http://maa.dshs.wa.gov/pdf/CherryStreet
DirectionsNMap.pdf or directions can be obtained by calling
(360) 725-1000), on November 27, 2012, at 10:00 a.m.
Date of Intended Adoption: Not sooner than November
28, 2012.
Submit Written Comments to: HCA Rules Coordinator,
P.O. Box 45504, Olympia, WA 98504-5504, delivery 626 8th
Avenue, Olympia, WA 98504, e-mail arc@hca.wa.gov, fax
(360) 586-9727, by 5:00 p.m. on November 27, 2012.
Assistance for Persons with Disabilities: Contact Kelly
Richters by November 19, 2012, TTY/TDD (800) 848-5429
or (360) 725-1307 or e-mail kelly.richters@hca.wa.gov.
Purpose of the Proposal and Its Anticipated Effects,
Including Any Changes in Existing Rules: The HCA is performing
the following actions: Amendment of these rules is
necessary due to changes the HCA is making to WAC 182-
Washington State Register, Issue 12-21 WSR 12-21-110
502-0005. The HCA is amending WAC 182-502-0005 to
implement 42 C.F.R. 455.410 which mandates states to
require all ordering, prescribing, or referring providers to be
enrolled as participating providers.
Statutory Authority for Adoption: RCW 41.05.021.
Statute Being Implemented: RCW 41.05.021.
Rule is not necessitated by federal law, federal or state
court decision.
Name of Proponent: HCA, governmental.
Name of Agency Personnel Responsible for Drafting:
Jason R. P. Crabbe, P.O. Box 45504, Olympia, WA 98504-
5504, (360) 725-1346; Implementation and Enforcement:
Chuck Agte (WAC 182-530-1000), (360) 725-1301 and
Ellen Silverman (WAC 182-531-0100), (360) 725-1570,
P.O. Box 45506, Olympia, WA 98504-5506.
No small business economic impact statement has been
prepared under chapter 19.85 RCW. The HCA has analyzed
the proposed new and amended rules and determines they
will not have an adverse economic impact on small businesses.
The preparation of a comprehensive small business
economic impact statement therefore is not required.
A cost-benefit analysis is not required under RCW
34.05.328. RCW 34.05.328 does not apply to HCA rules
unless requested by the joint administrative rules [review]
committee or applied voluntarily.
October 23, 2012
Kevin M. Sullivan
Rules Coordinator
AMENDATORY SECTION (Amending WSR 11-14-075,
filed 6/30/11, effective 7/1/11)
WAC 182-530-1000 Outpatient drug program—
General. (1) The purpose of the outpatient drug program is to
reimburse providers for outpatient drugs, vitamins, minerals,
devices, and drug-related supplies according to ((department))
medicaid agency rules and subject to the limitations
and requirements in this chapter.
(2) The ((department)) agency reimburses for outpatient
drugs, vitamins, minerals, devices, and pharmaceutical supplies
that are:
(a) Covered. Refer to WAC ((388-530-2000)) 182-530-
2000 for covered drugs, vitamins, minerals, devices, and
drug-related supplies and to WAC ((388-530-2100)) 182-
530-2100 for noncovered drugs and drug-related supplies;
(b) Prescribed by a provider with prescriptive authority
(see exceptions for family planning and emergency contraception
for women eighteen years of age and older in WAC
((388-530-2000)) 182-530-2000 (1)(b), and over-the-counter
(OTC) drugs to promote smoking cessation in WAC ((388-
530-2000)) 182-530-2000 (1)(g);
(c) Prescribed by:
(i) A provider with an approved core provider agreement;
or
(ii) A provider who is enrolled as a performing provider
on an approved core provider agreement;
(d) Within the scope of an eligible client's medical assistance
program;
(((d))) (e) Medically necessary as defined in WAC
((388-500-0005)) 182-500-0070 and determined according to
[ 125 ] Proposed